EPIM
CC icon

Evelyn Partners Investment Management’s Chemours CC Stock Holding History

Evelyn Partners Investment Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26K Sell
57
-46
-45% -$801 ﹤0.01% 392
2025
Q4 		$1.21K Hold
103
– – ﹤0.01% 395
2025
Q3 		$1.63K Hold
103
– – ﹤0.01% 388
2025
Q2 		$1.18K Sell
103
-87
-46% -$980 ﹤0.01% 392
2025
Q1 		$2.57K Sell
190
-64
-25% -$1.06K ﹤0.01% 386
2024
Q4 		$4.29K Buy
+254
New +$4.94K ﹤0.01% 381

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Evelyn Partners Investment Management's CC Position: Q1 2026 in Review

Evelyn Partners Investment Management reduced its Chemours (CC) stake by 45% in Q1 2026, selling an estimated $801 and leaving 57 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #392.

Evelyn Partners Investment Management first reported a position in CC in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.29K in Q4 2024. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Evelyn Partners Investment Management held 57 shares of Chemours worth $1.26K as of Q1 2026.
  • Evelyn Partners Investment Management sold 46 Chemours shares in Q1 2026, an estimated $801.
  • Chemours made up ﹤0.01% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #392 holding.
  • Evelyn Partners Investment Management first reported a position in Chemours in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management's Chemours position peaked at $4.29K in Q4 2024.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.